
Oct 24th, 2022
A research team is studying the use of nanoparticles to target and treat the aggressive brain cancer glioblastoma.
A research team is studying the use of nanoparticles to target and treat the aggressive brain cancer glioblastoma.
WE-Spark Health Institute details its accomplishments in its third annual Impact Report.
WE-Spark Health Institute has awarded more than $1 million in research grants.
A customized mobile and web app is intended to support collaborative research projects across Windsor-Essex.